HIVIS DNA vaccine

also known as HIVIS-DNA

Developed for: HIV infectious disease
Investigated by: Imperial College London · Instituto Nacional de Saúde, Mozambique · Karolinska Institutet · Ludwig-Maximilians - University of Munich · Mbeya medical research program · Medical Research Council
+4 more
· Muhimbili University of Health and Allied Sciences · National Institute for Medical Research, Tanzania · Swedish Institute for Infectious Disease Control · US Military HIV Research Program

today NCT01697007 · Ph 2

201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT01697007	Nov 2012 → Dec 2014	HIV infectious disease	Muhimbili University of Health and Allied Sciences	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	HIVIS DNA vaccine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01697007 ↗
Known as	HIVIS-DNA	“Subjects were primed three times with HIVIS-DNA and boosted twice with MVA-CMDR-HIV alone (n = 12) or MVA-CMDR combined with protein CN54rgp140 (n = 13).” PMID 30121146 ↗ Aug 2018